RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

Displaying 1..10 of 10 - per page
Order by
A white paper from Deloitte Life Sciences and Health Care, Deloitte Consulting, Zurich More
Maybe it is because of the well-educated workforce, maybe it is the advanced medical technology capabilities, and maybe it is the low cost? More
'High market penetration and top service,' Dr Anders Holmberg, Managing Director Dextech Medical, summarizes Pharmalicensing More
Pharmalicensing: A shop window for opportunities in the biotechnology industry More
The most critical challenge facing the global pharmaceutical industry today is the increasing cost of drug discovery and development and the increasing time to market. More
Very effective, useful portal allowing small companies to play big companies, - Dr Lehrke's summary of Pharmalicensing More
One of Pharmalicensing's recent clients is Gary Clark of Immunology Laboratories, based in Alabama in the United States. More
'We have made four deals through Pharmalicensing' Fabienne Roussel, University of Liège More
When making deals, you need to consider the answers to a number of questions. How is partnering changing? What is driving your potential partner's licensing decisions? What are the next trends going to be? More
PSI, located in Belgium, is a subsidiary company of Jubilant Organosys Ltd, a leading pharmaceutical and life science company in India, PSI has been with Pharmalicensing for a few years now. More
Displaying 1..10 of 10 - per page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us